Institute
of
Oncology
Research
Tools
Directory
Info Desk
IOR
An institute
affiliated to USI
The Institute
Research
Groups
Groups
Education
News and events
News and events
About
About
Staff
Staff
Foundation
Foundation
Facilities
Facilities
Open positions
Open positions
Support us
Support us
Partners & Supporters
Partners & Supporters
Contact
Contact
Bioinformatics Core Unit
Genomics Facility
Overview
Overview
Research Programs
Scientific Reports
Scientific Reports
Publications
Publications
Lymphoma and Genomics
Lymphoma and Genomics
Tumor Biology and Experimental Therapeutics
Tumor Biology and Experimental Therapeutics
Overview
Overview
Cancer Immunotherapy (Calcinotto)
Cancer Immunotherapy (Calcinotto)
Experimental Hematology (Rossi)
Experimental Hematology (Rossi)
Experimental Therapeutics (Catapano)
Experimental Therapeutics (Catapano)
Functional Cancer Genomics (Theurillat)
Functional Cancer Genomics (Theurillat)
Lymphoma Genomics (Bertoni)
Lymphoma Genomics (Bertoni)
Molecular Oncology (Alimonti)
Molecular Oncology (Alimonti)
Prostate Cancer Biology (Carbone)
Prostate Cancer Biology (Carbone)
Team
Education and training
Education and training
PhD Program
PhD Program
News
News
Events
Events
Events
News
All the years
IOR sets the stage for clinical study of new drug for the treatment of lymphomas and leukaemia
IOR takes part in innovative project for real-time Covid-19 testing device
IOR researchers suggest that androgen-deprivation treatments for prostate cancer could protect men from COVID-19
IOR paves the way for the clinical development of a therapy against prostate cancer metastasis
IOR lays the foundation for a new clinical trial against lymphomas
Pfizer Prize 2020, awards for IRB and IOR researchers in oncology and neurology
Full professorship at ETH Zurich granted to Prof. Dr. Andrea Alimonti
Movember at the Institute of Oncology Research
The Robert Wenner Prize for young cancer researchers goes to Andrea Alimonti
Prostate cancer, accolades for two IOR researchers
Prostate cancer research, important SNF grant goes to the IOR
IOR research paves the way for future clinical studies in lymphoma patients
IOR study reveals new way to eliminate cancer stem cells in prostate cancer
Castelgrande Lectures. New cancer therapies: a conference by Douglas Hanahan
Pfizer Prize 2019: accolades for researchers in Ticino
What is Ticino's contribution in medical research?
IOR Bellinzona, new frontiers of research in biomedicine
Prostate cancer: the dark side of immune response
Rectoverso: basic research, applied science
The cornerstone of the new Bellinzona campus is laid
« first
‹ previous
1
2
3
next ›
last »
